IGF2BP2 and osteosarcoma: In osteosarcoma, METTL14, highly expressed, prevents the degradation and enhances the translational efficiency of MN1 mRNA through the m6A‐IGF2BP2 axis, contributing to tumorigenicity and conferring all‐trans‐retinoic acid resistance.60